QIAGEN Secures FDA Clearance for Full QIAstat-Dx Gastrointestinal Panel Suite on High-Throughput QIAstat-Dx Rise System QIAGEN N.V., a global leader in molecular diagnostics, announced today a major advancement in its syndromic testing portfolio, as the U.S. Food and Drug Administration…
TIXiMED Announces Preclinical Success of Oral TIX100 in Preventing Weight Regain After GLP-1 Therapy TIXiMED, Inc., a clinical-stage pharmaceutical company at the forefront of developing novel therapies targeting metabolic disorders, has released encouraging preclinical data demonstrating the potential of its…
SystImmune and Bristol Myers Squibb announce interim Phase III data showing Iza-bren significantly improves outcomes in previously treated triple-negative breast cancer (TNBC) patients. SystImmune, Inc. and Bristol Myers Squibb have announced positive topline results from a pivotal Phase III clinical…
Evox Therapeutics Ltd collaborates with Rett Syndrome Research Trust to evaluate its ExoEdit® exosome-based gene editing platform as a potential therapeutic approach for Rett syndrome. Evox Therapeutics Ltd has announced the launch of a new strategic collaboration with the Rett…
New findings reinforce the clinical value of Aventa Lymphoma test for detecting diagnostically and therapeutically relevant genomic rearrangements in routine pathology samples. Arima Genomics, Inc., a precision oncology company harnessing whole-genome sequence and structural information to advance cancer therapy selection,…
New clinical study results highlight significant reductions in residual stone volume and follow-up health complications with Calyxo’s CVAC System. Calyxo, Inc., a medical device innovator transforming the treatment of kidney stones, has announced the peer-reviewed publication of pivotal clinical data…